ホーム › 黄斑変性症 › フロリダ州

フロリダ州における黄斑変性症の臨床試験

フロリダ州内の拠点で、黄斑変性症に関する14件の研究が参加者を募集しています。

フロリダ州内の都市

公式研究テキスト（英語）

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

Florida Eye Clinic (Site 130), Altamonte Springs
Retina Group of Florida (Site 070), Fort Lauderdale
Vitreo Retinal Associates, Gainesville
他10件

被験者募集中第2/3相

50歳以上 · 全性別 · 2026/10/02更新 · NCT07440225

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Retina Group of Florida, Fort Lauderdale
VitreoRetinal Associates, PA, Gainesville
Retina Specialty Institute, Pensacola
他1件

被験者募集中第2/3相

60歳以上 · 全性別 · 2026/09/30更新 · NCT06635148

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

Advanced Retina Institute-Ophthalmology, Bonita Springs
Advanced Research, Coral Springs
Retina Group of Florida, Fort Lauderdale
他11件

被験者募集中第3相

50歳〜85歳 · 全性別 · 2026/09/18更新 · NCT06541704

A Phase 2 Study of NT-101 Topical in Patients With Wet AMD

Advanced Retina Institute, Bonita Springs

被験者募集中第2相

50歳以上 · 全性別 · 2026/09/16更新 · NCT07811726

Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD

Florida Retina Institute, Orlando
Retina Specialty Institute, Pensacola
Retina Group of Florida, Sarasota
他1件

被験者募集中第2相

55歳以上 · 全性別 · 2026/09/10更新 · NCT06659445

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

Retina Specialty Institute, Pensacola

被験者募集中第1相

50歳以上 · 全性別 · 2026/09/03更新 · NCT03178149

A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults

University of Florida Health - UF Health Jacksonville, Jacksonville
University of Miami Health System - Bascom Palmer Eye Institute, Miami

被験者募集中観察研究

6歳以上 · 全性別 · 2026/08/25更新 · NCT07425574

4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration

Retina Group of Florida, Fort Lauderdale
Vitreo Retinal Associates, Gainesville
Florida Eye Associates, Melbourne
他2件

被験者募集中第1/2相

50歳以上 · 全性別 · 2026/08/21更新 · NCT05197270

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

Retina Group of Florida, Fort Myers
Florida Retina Institute, Orlando
Retina Group of Florida (Site 065), Sarasota
他1件

被験者募集中第2/3相

50歳以上 · 全性別 · 2026/08/06更新 · NCT07496567

Ixoberogene Soroparvovec (Ixo-vec) Contralateral Dosing Study in Participants With Neovascular Age-related Macular Degeneration

Adverum site 124, Deerfield Beach
Adverum site 176, Fort Lauderdale
Adverum site 168, Jacksonville

被験者募集中第2相

50歳以上 · 全性別 · 2026/08/05更新 · NCT07630649

Stem Cell Ophthalmology Treatment Study II

MD Stem Cells, Coral Springs

被験者募集中

18歳以上 · 全性別 · 2026/06/29更新 · NCT03011541

Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

ClearVista Clinical Research, Hudson
Florida Retina Institute, Orlando
Retina Specialty Institute, Pensacola
他3件

被験者募集中第3相

50歳以上 · 全性別 · 2026/04/16更新 · NCT07064759

Study to Evaluate the Safety of CG-P5 Peptide Eye Drops in Patients Diagnosed With Age-related Wet Macular Degeneration

CBCC Global Research Site:006, Deerfield Beach

被験者募集中第1相

50歳以上 · 全性別 · 2025/02/07更新 · NCT06132035

Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD

Sarasota Retina Institute, Sarasota

被験者募集中

65歳以上 · 全性別 · 2024/12/03更新 · NCT05438732

ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。